Provided by Tiger Trade Technology Pte. Ltd.

Alpha Tau Medical Warrant

1.14
+0.01000.88%
Post-market: 1.12-0.0200-1.75%16:00 EST
Volume:12.95K
Turnover:14.45K
Market Cap:80.23M
PE:-2.19
High:1.21
Open:1.21
Low:1.07
Close:1.13
52wk High:1.21
52wk Low:0.1300
Shares:70.38M
Float Shares:70.38M
Volume Ratio:0.31
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5213
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Company Profile

Company Name:
Alpha Tau Medical Warrant
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.